Common Diabetes Drug Januvia May Contain Traces of Carcinogen, FDA Says
FRIDAY, Aug. 12, 2022 (HealthDay News) – The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug Administratio…
Learn MoreThree At-Home COVID Tests Needed to Confirm Negative Result, FDA Says
FRIDAY, Aug. 12, 2022 (HealthDay News) — People who test at home after being exposed to COVID-19 should take the test three, not two, times to make sure they’re not infected, the U.S. Food and Drug Administration said Thursday.In issuing its new safe…
Learn More1 in 4 Kids Hospitalized With COVID Have Symptoms Months Later
FRIDAY, Aug. 12, 2022 (HealthDay News) — More than a quarter of kids hospitalized with COVID-19 or a complication called multisystem inflammatory syndrome (MIS-C) continue to have health problems more than two months later, a new study finds.A follow…
Learn MoreWhen Adults Sign Up for Medicaid, Kids Can Benefit
FRIDAY, Aug. 12, 2022 (HealthDay News) — Some adults who sign up for Medicaid also bring their unenrolled but eligible kids into the system, a new study reports.For every nine adults who gained access to Medicaid in Oregon due to a special enrollment…
Learn MoreWhen Older Dogs’ Hearing Fades, Risk of Dementia Rises
FRIDAY, Aug. 12, 2022 (HealthDay News) — When dogs’ hearing fades, their mental skills follow, new research reveals.For the study, the researchers examined the link between hearing loss in aging dogs and dementia. The findings shed light on ways sens…
Learn MoreMost Eutylone-Involved Deaths in 2020 Occurred in Two States
THURSDAY, Aug. 11, 2022 (HealthDay News) — Most eutylone-involved deaths in 2020 occurred in two states, and deaths commonly co-involved illicitly manufactured fentanyls (IMFs) and cocaine or methamphetamine, according to research published in the…
Learn MoreCDC Eases COVID-19 Social Distancing Guidance
THURSDAY, Aug. 11, 2022 (HealthDay News) — The U.S. Centers for Disease Control and Prevention said Thursday it has loosened its COVID-19 social distancing recommendations as the American public learns to live with the virus in its midst. The new gui…
Learn MoreSurvival Benefit Seen With Triple Therapy for Severe COVID-19
THURSDAY, Aug. 11, 2022 (HealthDay News) — For patients with severe COVID-19 requiring high flow nasal cannula (HFNC), triple therapy of dexamethasone, remdesivir, and baricitinib is associated with significant survival benefit compared with dual t…
Learn More